| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 19900-84-6 | Methane,isothiocyanatomethoxy-; Isothiocyanicacid, methoxymethyl ester (8CI); Methoxymethyl isothiocyanate |  | C3H5NOS | 詳情 | 供應商 | |
| 21667-10-7 | myo-Inositol,4-(dihydrogen phosphate); (?à)-myo-Inositol-4-phosphate; Inositol 4-monophosphate; Inositol 4-phosphate; myo-Inositol 4-phosphate |  | C6H13O9P | 詳情 | 供應商 | |
| 3555-86-0 | Methanone,phenyl(2,4,6-trihydroxyphenyl)-; Benzophenone,2,4,6-trihydroxy- (6CI,7CI,8CI); 2,4,6-Trihydroxybenzophenone; Phlorobenzophenone |  | C13H10O4 | 詳情 | 供應商 | |
| 25727-91-7 | Morpholine,4-hexadecyl-; 4-(n-Hexadecyl)morpholine; 4-Hexadecylmorpholine; N-Hexadecylmorpholine; N-Palmitylmorpholine |  | C20H41NO | 詳情 | 供應商 | |
| 69579-74-4 | Methanone,(3-hydroxy-2-furanyl)phenyl-; Adustin |  | C11H8O3 | 詳情 | 供應商 | |
| 2917-64-8 | Methanol,1-(ethyldimethylsilyl)-, 1-acetate; Methanol,(ethyldimethylsilyl)-, acetate (7CI,8CI,9CI); (Ethyldimethylsilyl)methylacetate; NSC 96807 |  | C7H16O2Si | 詳情 | 供應商 | |
| 27922-28-7 | Morpholine,4-[2-[(4-fluorophenyl)sulfonyl]ethyl]-, hydrochloride (1:1); Morpholine,4-[2-[(p-fluorophenyl)sulfonyl]ethyl]-, hydrochloride (8CI) |  | C12H17ClFNO3S | 詳情 | 供應商 | |
| 64467-61-4 | Morpholine,4-(1,1-dipropylbutyl)-, hydrochloride (1:1); Morpholine,4-(1,1-dipropylbutyl)-, hydrochloride (9CI) |  | C14H30ClNO | 詳情 | 供應商 | |
| 173469-71-1 | methyl 2-(3-methyl-4-oxo-2-phenyl-chromen-6-yl)butanoate |  | C21H20O4 | 詳情 | 供應商 | |
| 101893-08-7 | Morpholine,4-[2-[[5-bromo-2-(pentyloxy)phenyl]methoxy]ethyl]-; Morpholine,4-[2-(5-bromo-2-pentyloxybenzyloxy)ethyl]- (6CI) |  | C18H28BrNO3 | 詳情 | 供應商 | |
| 31161-46-3 | Methanone,(5-bromo-2-thienyl)phenyl-; Ketone,5-bromo-2-thienyl phenyl (8CI); 2-Benzoyl-5-bromothiophene; 5-Benzoyl-2-bromothiophene; NSC 170817 |  | C11H7BrOS | 詳情 | 供應商 | |
| 26020-13-3 | Methanesulfonic acid,1-nitrilo-; Cyanosulfuricacid (8CI,9CI) |  | CHNO3S | 詳情 | 供應商 | |
| 27117-07-3 | Morpholine,4-[2-[3-methyl-5-(3-pyridinyl)-1H-pyrazol-4-yl]diazenyl]-; Pyrazole,3-methyl-4-(morpholinoazo)-5-(3-pyridyl)- (8CI); NSC 131239 |  | C13H16N6O | 詳情 | 供應商 | |
| 106521-51-1 | Methanesulfonamide,N-[4-[(4-chloro-9-acridinyl)amino]-3-(dimethylamino)phenyl]- |  | C22H21ClN4O2S | 詳情 | 供應商 | |
| 12033-19-1 | Molybdenum nitride(MoN); Molybdenummononitride |  | MoN | 詳情 | 供應商 | |
| 14410-23-2 | Montanastatin (9CI); 1,7,13,19-Tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octone,3,6,9,15,18,21-hexaisopropyl-12,24-dimethyl- (7CI); 1,7,13,19-Tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octone,3,6,9,15,18,21-hexaisopropyl-12,24-dimethyl-, stereoisomer (8CI); Valinomycin,9-de(D-2-hydroxy-3-methylbutanoicacid)-10-de-D-valine-11-de(L-2-hydroxypropanoic acid)-12-de-L-valine-; 1,7,13,19-Tetraoxa-4,10,16,22-tetraazacyclotetracosane, cyclic peptide deriv.; Cyclo[(2R)-2-hydroxy-3-methylbutanoyl-D-valyl-(2S)-2-hydroxypropanoyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-D-valyl-(2S)-2-hydroxypropanoyl-L-valyl]; Montanastatin (Streptomyces anulatus); Octavalinomycin |  | C36H60N4O12 | 詳情 | 供應商 | |
| 1202-62-6 | Methanimidamide,N'-(4-methoxyphenyl)-N,N-dimethyl-; Formamidine,N'-(p-methoxyphenyl)-N,N-dimethyl- (7CI,8CI); N'-(4-Methoxyphenyl)-N,N-dimethylformamidine; N'-(p-Methoxyphenyl)-N,N-dimethylformamidine |  | C10H14N2O | 詳情 | 供應商 | |
| 16519-98-5 | Methyl, iodo-(6CI,8CI,9CI); Iodomethyl; Iodomethyl radical |  | CH3I* | 詳情 | 供應商 | |
| 27236-35-7 | Morpholine,4-(1-oxoundecenyl)- (9CI); Morpholine,4-(undecenoyl)- (8CI) |  | C15H27NO2 | 詳情 | 供應商 | |
| 2440-42-8 | Mercury, ethyliodo-(7CI,8CI,9CI); Ethylmercuryiodide (6CI); Ethylmercuric iodide; NSC 203103 |  | C2H5HgI | 詳情 | 供應商 | |